To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of including nanopore sequencing-based brain tumour methylome classification in the National Genomic Test Directory.
The Department funded the Cancer 2.0 initiative in 2021, delivered by Genomics England in close partnership with NHS England. The three-year programme demonstrated that nanopore sequencing-based brain tumour classification demonstrates significant promise...
Brain: Tumours